Paul E. Oberstein
Impact in
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 58
- Pancreatic and Hepatic Oncology Research 31
- Cancer Immunotherapy and Biomarkers 21
- Colorectal Cancer Treatments and Studies 11
- Lung Cancer Research Studies 8
-
- Cancer Genomics and Diagnostics 17
- Co-authors
- Kenneth P. Olive (6 shared papers)Stephen A. Sastra (3 shared papers)Carmine F. Palermo (3 shared papers)Ian Tattersall (1 shared paper)Jan Kitajewski (1 shared paper)Dafydd Thomas (1 shared paper)Emily T. Mirek (1 shared paper)C. Benedikt Westphalen (1 shared paper)
- Journals
- Journal of Clinical Oncology (34 papers)Cancer Research (3 papers)Clinical Cancer Research (2 papers)JAMA Oncology (2 papers)Cancer (1 paper)
- Partner nations
- United StatesSpainSwitzerland
In The Last Decade
Paul E. Oberstein
63 papers receiving 2.8k citations
Paul E. Oberstein's Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 2.2k
- Cancer Research 745
- Immunology 625
- Biotechnology 153
- Molecular Biology 934
Countries citing papers authored by Paul E. Oberstein
This map shows the geographic impact of Paul E. Oberstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Oberstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Oberstein more than expected).
Fields of papers citing papers by Paul E. Oberstein
This network shows the impact of papers produced by Paul E. Oberstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Oberstein. The network helps show where Paul E. Oberstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul E. Oberstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma Hit paper breakdown → | 2014 | 1513 |
| 2 | HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma Hit paper breakdown → | 2017 | 365 |
| 3 | 2013 | 242 | |
| 4 | 2017 | 117 | |
| 5 | 2019 | 114 | |
| 6 | 2017 | 67 | |
| 7 | 2020 | 43 | |
| 8 | 2017 | 39 | |
| 9 | 2019 | 37 | |
| 10 | 2012 | 18 | |
| 11 | 2013 | 16 | |
| 12 | 2022 | 14 | |
| 13 | 2012 | 13 | |
| 14 | 2022 | 13 | |
| 15 | 2023 | 13 | |
| 16 | 2022 | 12 | |
| 17 | 2022 | 11 | |
| 18 | 2023 | 10 | |
| 19 | Novel agents in the treatment of unresectable neuroendocrine tumors. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. | 2011 | 10 |
| 20 | 2023 | 10 |
About Paul E. Oberstein
Paul E. Oberstein is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Molecular Biology, having authored 70 papers that have together received 2.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (31 papers), Cancer Immunotherapy and Biomarkers (21 papers), Cancer Genomics and Diagnostics (17 papers), Colorectal Cancer Treatments and Studies (11 papers), Gastric Cancer Management and Outcomes (9 papers), Neuroendocrine Tumor Research Advances (9 papers), Lung Cancer Research Studies (8 papers) and Cancer Research and Treatments (7 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (745 citations), Immunology (625 citations), Biotechnology (153 citations) and Molecular Biology (934 citations). Paul E. Oberstein has collaborated with scholars based in United States, Spain and Switzerland. Frequent co-authors include Kenneth P. Olive, Stephen A. Sastra, Carmine F. Palermo, Ian Tattersall, Jan Kitajewski, Dafydd Thomas, Emily T. Mirek, C. Benedikt Westphalen, Maite G. Fernández‐Barrena and Andrew D. Rhim. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, JAMA Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.